CTLA4 and neoplasm: Li SY et al. [31] constructed nanoparticles to deliver CTLA-4 siRNA (NPsiCTLA-4) and showed the ability of this siRNA delivery system to enter T cells both in vitro and in vivo, eliminating the immunosuppression in the tumor microenvironment.